Agentic AI as a Driver of Innovation and Change Management in Organizations: A Conceptual Review and Framework for Technology-Enabled Transformation
DOI:
https://doi.org/10.47604/ijts.3916Keywords:
Agentic AI, Innovation Management, Change Management, Technology-Enabled Transformation, Responsible AI GovernanceAbstract
Purpose: This paper investigates the potential of Agentic Artificial Intelligence (AI) to be a driver of innovation and change management in organizations undergoing technology-enabled transformation. It addresses the impact of Agentic AI features, such as autonomy, reasoning, planning, tool use, memory, and multi-agent coordination, on innovation processes, organizational readiness, human–AI interaction, as well as responsible governance.
Methodology: The methodology used in this paper was a desk-based conceptual review design, which was supported by framework development. The literature was identified through a concept-driven structured search process using ScienceDirect and Emerald Insight. The concepts reviewed were the five interrelated concepts: Agentic AI/AI agents, AI and innovation management, change management/AI readiness, digital transformation/technology-enabled transformation, and responsible AI governance. A conceptual and thematic synthesis method of analysis was used to analyze the selected literature.
Findings: The review revealed that Agentic AI is able to assist with ideation, knowledge recombination, experimentation, process redesign, business model innovation, and workflow coordination. However, transformation does not occur automatically. The factors of organizational readiness, data quality, leadership support, employee trust, and role clarity, along with human-AI interaction and responsible governance, are essential for transformation based on Agentic AI. The paper also noted that Agentic AI presents a governance paradox because while it can have value due to autonomy, the greater the autonomy, the more likely there will be a need for human oversight, audit trails, escalation protocols, transparency, and restrictions on autonomous activity.
Unique Contribution to Theory, Practice and Policy: The paper is unique in bringing together, in a single conceptual framework, socio-technical, dynamic capability, AI-readiness, change-management, and responsible AI governance views on the topic of Agentic AI-enabled transformation. It makes a contribution to practice by demonstrating that Agentic AI can be used as an organizational transformation capability, not as a technology with a narrow scope of practice. It helps shape policy by highlighting the importance of establishing real-world, reliable governance standards, accountability measures, controlled testing spaces, and sector-specific guidance for the responsible adoption of Agentic AI.
Downloads
References
Arslan GG, Eşer İ. Yaşlılara verilen eğitimin ilaç kullanım uyumuna etkisinin incelenmesi. Turk J Geriatr, 2005;8(3):131-40.
Aşılar RH, Gözüm S. Hypertensive individuals’ use of complementary health approaches and its effect on adherence with antihypertensive medication treatment. TJFMPC, 2017;11(4):235-44. DOI: 10.21763/tjfmpc.359689
Bogden P, Abbott R, Williamson P, Onopa J, Koontz L. Comparing standard care with a physician pharmacist team approach for uncontrolled hypertension. J Gen Intern Med, 1998;13:740-5. DOI: 10.1046/j.1525-1497.1998.00225.x
Bosworth H, Olsen M, Gentry P, Orr M, Dudley T, McCant F, et al. Nurse Administired Telephone Intervention for Blood Pressure. Patient Educ Couns, 2005;57(1):5-7. DOI: 10.1016/j.pec.2004.03.011
Clark M, Curran C, Noji A. The effects of community health nurse monitoring on hypertension identification and control. Public Health Nurs, 2000;17(6):452-9. DOI:10.1046/j.1525-1446.2000.00452.x
Çakır H. Hipertansiyon Hastalarına Verilen Eğitimin Sağlıklı Yaşam Biçimi Davranışları ve Hipertansiyon Yönetimine Etkisi [Yüksek Lisans Tezi]. İstanbul: Marmara Üniversitesi Sağlık Bilimleri Enstitüsü, 2003. Danışman: Doç. Dr. Rukiye Pınar.
Castro MS, Fuchs FD, Santos MC, Maximiliano P, Gus M, Moreira LB, et al. Pharmaceutical care program for patients with uncontrolled hypertension. Am J Hypertens, 2006;19(5):528-33. DOI: 10.1016/j.amjhyper.2005.11.009
Cingil D, Delen S, Akseoğlu A. Karaman Merkezinde Yaşayan Hipertansiyon Hastalarının İlaç Kullanım Durumlarının ve Bilgilerinin İncelenmesi. Turk Kardiyol Dern Arş, 2009;37(8):551-6. DOI: 10.5543/tkda.2009.47135
Grandi A, Maresca A, Sessa A, Stella R, Ponti D, Barlocco E, et al. Longitudinal study on hypertension control in primary care. Am J Hypertens, 2006;19(2):140-5. DOI: 10.1016/j.amjhyper.2005.06.034
Gögen S, Özdemir Y. Birinci basamak sağlık kuruluşlarında hipertansif hastaların takibi. TSK Koruyucu Hekim Bült, 2005;4(1):8-15.
Hunt JS, Siemienczuk J, Touchette D, Payne N. Impact of educational mailing on the blood pressure of primary care patients with mild hypertension. J Gen Intern Med, 2004;19:925-30. DOI: 10.1111/j.1525-1497.2004.40046.x
Izzo J, Black H. Essentials Hypertension. İstanbul: Nobel Tıp Kitapevleri, 2004. p. 1-536.
Ji Y, Ma Z, Peppelenbosch M, Pan Q. Potential association between COVID-19 mortality. Lancet Glob Health, 2020;8(4):2214-9. DOI: 10.1016/S2214-109X(20)30068-1
Kaplan N. Clinic Hypertension. İstanbul: Turgut Yayıncılık, 2003.
Lee JK, Grace KA, Taylor AJ. Effect of pharmacy care program on medication adherence and persistence, blood pressure and low-density lipoprotein cholesterol. JAMA, 2006;296:2563-71. DOI: 10.1001/jama.296.21.joc60162
Malhotra R, Angelique C, Malhotral C. Prevalence, awareness, treatment and control of hypertension in the elderly population of Singapore. Hypertens Res, 2010;33:1223-31. DOI: 10.1038/hr.2010.177
McIntosh K, Peiris J. Coronaviruses. Clin Virol. 2009;3rd Ed:1155-71.
Önal E, Tümerdem Y. Yaşlılıkta Hipertansiyon Turk Geriatri Derg, 2011;4(4):141-5.
Pena GC, Thorogood M, Armstrong B, et al. Pragmatic randomized trial of home visits by a nurse elderly people with hypertension in Mexico. Int J Epidemiol, 2001;30(6):1485-92. DOI: 10.1093/ije/30.6.1485
Rudd P, Miller NH, Kaufman J, et al. Nurse management for hypertension. Am J Hypertens, 2004;17(10):921-7. DOI: 10.1016/j.amjhyper.2004.06.006
Swetkey L, Erlinger T, Wollmer W. Effects of lifestyle modifications on blood pressure by race, sex, hypertension status and age. J Hum Hypertens, 2005;19(1):21-31. DOI: 10.1038/sj.jhh.1001770
Şarlı Ş. Hipertansiyon Hastalığı Olanlarda Tedaviye Uyum, Etkileyen Faktörler ve Yaşam Kalitesinin Değerlendirilmesi [Tıpta Uzmanlık Tezi]. Kayseri: Erciyes Üniversitesi Tıp Fakültesi, 2011. Danışman: Doç. Dr. İskender Gün.
Stergiou GS, Karotsis AK, Symeonidis A, Vassilopoulou VA. Aggressive blood pressure control in general practice study: can the new targets be reached?. J Hum Hypertens, 2003;17:767-73. DOI: 10.1038/sj.jhh.1001610
Tokem Y, Karadakovan A. Yaşlı bireylere verilen bireyselleştirilmiş ilaç eğitim programının ilaç yönetimleri üzerine etkisinin incelenmesi. Sağlık Toplum, 2004;79-87.
Worldometer. Worldometer: https://www.worldometers.info/coronavirus/. 2020 Apr.
W Z, McGoogan J. Characteristics of and important lessons from the coronavirus. JAMA, 2020;323(13):1239-42. DOI: 10.1001/jama.2020.2648
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Fatma Albalooshi
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution (CC-BY) 4.0 License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
